Laure Ory-Lavollée
Plus aucun poste en cours
Profil
Laure Ory-Lavollée, who worked at Diatos SA and Cellectis SA, was a director at both firms.
She also worked as an analyst at Puilaetco in 2002.
Anciens postes connus de Laure Ory-Lavollée
| Sociétés | Poste | Fin |
|---|---|---|
Diatos SA
 Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Directeur/Membre du Conseil | 15/09/2009 |
| Puilaetco | Analyst-Equity | 15/05/2002 |
| CELLECTIS S.A. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CELLECTIS S.A. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Diatos SA
Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Health Technology |
| Puilaetco | Finance |
